ArticleBJU international2020

The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression.

Barbara M Wollersheim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.